ISCT 2020 Paris Virtual CMLE Approved Program Evaluation Survey

Question Title

1. Contact Information (Required.)

Name

Company

Address 1

Address 2

City/Town

State/Province

Zip/Postal Code

Country

Email Address

Question Title

2. Professional Category (Required.)

MT(ASCP)

HT/HTL(ASCP)

MLT(ASCP)

PBT(ASCP)

CT(ASCP)

Other, please specify

Question Title

3. Professional Practice Category (Required.)

Technologist

Research (pre-clinical)

Manager/Supervisor

Translational Development

Medical Director

QA/Regulatory

Other, please specify

Question Title

4. Years of Experience (Required.)

0-1 Year

2-5 Years

6-10 Years

11-20 Years

20+ Years

Session Evaluations
Please complete the evaluation for all of the sessions you attended/streamed.

Question Title

5. THURSDAY, MAY 28th, 2020 - LIVE Broadcast Sessions - CMLE Credits: 1.5 per session

The speakers’ level of expertise regarding content presented was:

	Excellent	Very Good	Good	Fair	Poor	N/A
ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens"	ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens" Excellent	ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens" Very Good	ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens" Good	ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens" Fair	ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens" Poor	ISCT CSO GLOBAL SHOWCASE ON COVID-19, PART I "The Force Awakens" N/A
Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates	Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates Excellent	Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates Very Good	Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates Good	Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates Fair	Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates Poor	Plenary Session - Mesenchymal Stromal Cells: Full Circle From Basic Research Insights to Clinical Trial Updates N/A
Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments	Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments Excellent	Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments Very Good	Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments Good	Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments Fair	Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments Poor	Plenary Session - Advances and Emerging Technologies in Immune-Mediated Cancer Treatments N/A
Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling	Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling Excellent	Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling Very Good	Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling Good	Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling Fair	Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling Poor	Plenary Satellite Session - iPSC for Cardiovascular Regenerative Medicine and Disease Modelling N/A
Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent	Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent Excellent	Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent Very Good	Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent Good	Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent Fair	Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent Poor	Presidential Plenary - Mastering Pluripotent Cells with Therapeutic Intent N/A
Plenary Satellite Session - Gene Therapy Clinical Trials	Plenary Satellite Session - Gene Therapy Clinical Trials Excellent	Plenary Satellite Session - Gene Therapy Clinical Trials Very Good	Plenary Satellite Session - Gene Therapy Clinical Trials Good	Plenary Satellite Session - Gene Therapy Clinical Trials Fair	Plenary Satellite Session - Gene Therapy Clinical Trials Poor	Plenary Satellite Session - Gene Therapy Clinical Trials N/A

ISCT 2020 Paris Virtual CMLE Approved Program Evaluation

DAY 1 - LIVE SESSIONS

Question Title

1. Contact Information (Required.)

Question Title

2. Professional Category (Required.)

Question Title

3. Professional Practice Category (Required.)

Question Title

4. Years of Experience (Required.)

Question Title

5. THURSDAY, MAY 28th, 2020 - LIVE Broadcast Sessions - CMLE Credits: 1.5 per session

The speakers’ level of expertise regarding content presented was:

Question Title

6. Total Credits on Thursday:

Question Title

* 1. Contact Information (Required.)

Question Title

* 2. Professional Category (Required.)

Question Title

* 3. Professional Practice Category (Required.)

Question Title

* 4. Years of Experience (Required.)

Question Title

* 5. THURSDAY, MAY 28th, 2020 - LIVE Broadcast Sessions - CMLE Credits: 1.5 per sessionThe speakers’ level of expertise regarding content presented was:

Question Title

* 6. Total Credits on Thursday:

1. Contact Information (Required.)

2. Professional Category (Required.)

3. Professional Practice Category (Required.)

4. Years of Experience (Required.)

5. THURSDAY, MAY 28th, 2020 - LIVE Broadcast Sessions - CMLE Credits: 1.5 per session

The speakers’ level of expertise regarding content presented was:

6. Total Credits on Thursday: